Insulin

Moments in history

Marc Rendell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The isolation of insulin by Banting and Best in 1922 was a historic event of life-saving importance. Thousands of individuals doomed to die of type I diabetes were saved. The inspiring story of insulin continued to grow and evolve with the development of PZI, NPH, and lente insulins. The advent of production of human insulin from recombinant DNA brought an end to the extraction of insulin from animal pancreas. Modification of the amino acid sequences of insulin led to new forms of fast-acting insulin, such as lispro, aspart, and glulisine, and to long-acting insulins like glargine and detemir. The technology of insulin pumps advanced from large, cumbersome equipment to present-day devices no bigger than a hand calculator. The accuracy of implantable glucose sensors improved progressively, culminating in the approval of devices that will soon exert reliable feedback control of insulin pumps. Transplantation of the pancreas offers a cure for type I diabetes, and the development of islet cell transplantation continues. It is now appreciated that islet cells regenerate in the normal pancreas, and islet cell neogenesis agents have been identified and may eventually contribute to the reversal of diabetes.

Original languageEnglish
Pages (from-to)95-100
Number of pages6
JournalDrug Development Research
Volume69
Issue number3
DOIs
StatePublished - May 2008

Fingerprint

History
Insulin
Medical problems
Islets of Langerhans
Type 1 Diabetes Mellitus
Device Approval
Pancreas
Lente Insulin
Long-Acting Insulin
Insulin Lispro
Pumps
Isophane Insulin
Glucose sensors
Pancreas Transplantation
Equipment and Supplies
Islets of Langerhans Transplantation
Recombinant DNA
Cell Transplantation
Feedback control
Amino Acid Sequence

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Insulin : Moments in history. / Rendell, Marc.

In: Drug Development Research, Vol. 69, No. 3, 05.2008, p. 95-100.

Research output: Contribution to journalArticle

Rendell, Marc. / Insulin : Moments in history. In: Drug Development Research. 2008 ; Vol. 69, No. 3. pp. 95-100.
@article{8d7e7a0ba92542b39e55bc082870f356,
title = "Insulin: Moments in history",
abstract = "The isolation of insulin by Banting and Best in 1922 was a historic event of life-saving importance. Thousands of individuals doomed to die of type I diabetes were saved. The inspiring story of insulin continued to grow and evolve with the development of PZI, NPH, and lente insulins. The advent of production of human insulin from recombinant DNA brought an end to the extraction of insulin from animal pancreas. Modification of the amino acid sequences of insulin led to new forms of fast-acting insulin, such as lispro, aspart, and glulisine, and to long-acting insulins like glargine and detemir. The technology of insulin pumps advanced from large, cumbersome equipment to present-day devices no bigger than a hand calculator. The accuracy of implantable glucose sensors improved progressively, culminating in the approval of devices that will soon exert reliable feedback control of insulin pumps. Transplantation of the pancreas offers a cure for type I diabetes, and the development of islet cell transplantation continues. It is now appreciated that islet cells regenerate in the normal pancreas, and islet cell neogenesis agents have been identified and may eventually contribute to the reversal of diabetes.",
author = "Marc Rendell",
year = "2008",
month = "5",
doi = "10.1002/ddr.20232",
language = "English",
volume = "69",
pages = "95--100",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Insulin

T2 - Moments in history

AU - Rendell, Marc

PY - 2008/5

Y1 - 2008/5

N2 - The isolation of insulin by Banting and Best in 1922 was a historic event of life-saving importance. Thousands of individuals doomed to die of type I diabetes were saved. The inspiring story of insulin continued to grow and evolve with the development of PZI, NPH, and lente insulins. The advent of production of human insulin from recombinant DNA brought an end to the extraction of insulin from animal pancreas. Modification of the amino acid sequences of insulin led to new forms of fast-acting insulin, such as lispro, aspart, and glulisine, and to long-acting insulins like glargine and detemir. The technology of insulin pumps advanced from large, cumbersome equipment to present-day devices no bigger than a hand calculator. The accuracy of implantable glucose sensors improved progressively, culminating in the approval of devices that will soon exert reliable feedback control of insulin pumps. Transplantation of the pancreas offers a cure for type I diabetes, and the development of islet cell transplantation continues. It is now appreciated that islet cells regenerate in the normal pancreas, and islet cell neogenesis agents have been identified and may eventually contribute to the reversal of diabetes.

AB - The isolation of insulin by Banting and Best in 1922 was a historic event of life-saving importance. Thousands of individuals doomed to die of type I diabetes were saved. The inspiring story of insulin continued to grow and evolve with the development of PZI, NPH, and lente insulins. The advent of production of human insulin from recombinant DNA brought an end to the extraction of insulin from animal pancreas. Modification of the amino acid sequences of insulin led to new forms of fast-acting insulin, such as lispro, aspart, and glulisine, and to long-acting insulins like glargine and detemir. The technology of insulin pumps advanced from large, cumbersome equipment to present-day devices no bigger than a hand calculator. The accuracy of implantable glucose sensors improved progressively, culminating in the approval of devices that will soon exert reliable feedback control of insulin pumps. Transplantation of the pancreas offers a cure for type I diabetes, and the development of islet cell transplantation continues. It is now appreciated that islet cells regenerate in the normal pancreas, and islet cell neogenesis agents have been identified and may eventually contribute to the reversal of diabetes.

UR - http://www.scopus.com/inward/record.url?scp=49449101277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49449101277&partnerID=8YFLogxK

U2 - 10.1002/ddr.20232

DO - 10.1002/ddr.20232

M3 - Article

VL - 69

SP - 95

EP - 100

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 3

ER -